Research:  The Promise Of Tomorrow

Education

Awareness

Research

Volunteer

Donate

Home

 

Conquer Chiari has an active program of awarding Research Grants and organizing Conferences in support of the Goals and Objectives identified in our Research Agenda.

Research Grants:  Ongoing, Completed
Research Conferences
Conquer Chiari Research Agenda
The Importance of Research

Ongoing Research Funded By Conquer Chiari -

Total Active Research Projects  = $ 382,600
Total Completed Research          =  $   50,000
Total Research Funded To Date = $ 432,600

Dynamic MRI and Quantitative MR CSF Flow Studies in Chiari I Malformations
A $50,000 research grant to the University of Michigan (Dr. Bapuraj) to study the effect of neck position on tonsillar crowding and CSF flow in children with Chiari.  While many people believe that neck flexion and especially extension negatively impacts Chiari, this study will determine whether this is true and provide quantitative data, which may be valuable in evaluating patients with mild or sporadic symptoms.

MR Measurement of CSF Wave Speed, Distribution of CSF Velocity and Pressure, Longitudinal
Impedance, and Skull Base Geometry in Chiari Patients
A $120,000 research grant to a collaboration of researchers to look for new, objective indicators of symptomatic Chiari. Published research has shown time and again that the old definition of Chiari, based on the amount of tonsillar herniation below the foramen magnum, is not a good indicator of symptom severity or the need for surgery.  The overall aim of this project is to identify novel methods of analysis that distinguish symptomatic Chiari I patients who require treatment, from individuals with asymptomatic Chiari I (incidental tonsial ectopia) using advanced imaging and engineering techniques.

Molecular Neural Crest-mesoderm Interactions and Control Networks Affected in Chiari (Phase II)

A $75,000 grant to extend the work of Dr. Koentges in identifying the regulatory regions (CRM) directing the gene expressions in the development of the cranial base and neck regions.  The research will use advanced genomic analysis techniques to identify key CRMs in the neural crest components of the skull and neck regions as related to key, unique clinical features of Chiari.  Establishing the full host of cis-regulatory regions potentially implicated in Chiari will assist clinicians and human geneticists in resolving the varied symptoms associated with the syndrome and create unique profiles that may be predictive of diagnosis and treatment outcomes as part of a comprehensive re-classification based on genetic grounds.

 

Cognitive Function in Chiari Malformation

A $75,000 grant to Dr. David Frim, at the University of Chicago, to address one of the most pressing questions Chiari patients have:  Does Chiari affect thinking, memory, and concentration?  Dr. Frim will employ techniques developed in studying hydrocephalus to evaluate the cognitive impact of Chiari on both pediatric and adult patients.  If a cognitive profile associated with Chiari is identified, it can then be used to develop therapeutic interventions to lessen the cognitive impact of Chiari and improve outcomes.

 

Characterization of Chiari Clinical Subtypes by Expression Analysis

A $54,000 grant to Dr. Simon Gregory, a geneticist at Duke University, to perform genetic analysis on pediatric Chiari patients undergoing surgery, in order to identify clinical sub-groups.  Dr. Gregory will examine blood and tissue samples from the patients and correlate the genetic expression(s) with clinical indicators, such as skull dimensions and the presence of a syrinx.  The Conquer Chiari Research Conference in 2008 highlighted the identification of specific sub-groups of Chiari patients as critical to improving treatments and outcomes, especially in children.

 

Chiari Symptom Profile
A $3,000 grant to Dr. Diane Mueller of the University of Missouri to develop a statistically validated measure of Chiari symptoms.  Such a tool will be vital in advancing the clinical care of Chiari and enabling more scientifically sound research.  Note:  Since Dr. Mueller is on the Board of Directors of Conquer Chiari, she is not personally taking any funds associated with this project, but rather is volunteering her time and expertise to oversee it.

Prospective Evaluation of Release of Tethered Spinal Cord in Patients with Chiari I Malformation, Syringomyelia, or Scoliosis 
A two-year clinical grant to Dr. John Oro, at the Chiari Care Center, to study the effects of tethered cord release surgery in patients with clinical signs and symptoms of tethered cord and Chiari and/or syringomyelia.  The relationship between tethered cord and Chiari is controversial as is the treatment of patients with indications of both.  This well structured, prospective research study should provide insight into the connection between tethered cord and Chiari and how best to treat such patients.

Completed Research

Microarray-based discovery of genes active in post-otic neural crest at critical stages and places of head morphogenesis affected in Chiari I/ II (Phase 1)
A $50,000 research grant awarded to Dr. Georgy Koentges to employ a mouse model to identify what genes are active at critical stages of embryological development which are believed to correspond to when the defects associated with Chiari occur.  According to Dr. Koentges, “As a direct results of this grant, our investigations into PONC cells has lead to the establishment of the molecular development of the tissues implicated in the variety of symptoms of Chiari.”

 

RESEARCH CONFERENCES

Chiari Malformation:  State of the Research & New Directions (November 2008):

A two day professional research conference, sponsored by the National Institute of Neurological Disorders and Stroke (NINDS), which brought together the top physicians and researchers in the field in order to establish the current state of knowledge regarding Chiari malformation, discuss recent developments in Chiari research, and develop research recommendations to advance the state of knowledge and care for Chiari malformation. The meeting presentations breakout working group sessions on: Definition & Pathophysiology, Symptoms & Diagnostic Criteria, Engineering & Imaging Techniques, Treatment, Pediatric Issues, and Related Conditions.

A video web archive of the presentations is available for viewing here:

Chiari Conference 2008

UIC/Conquer Chiari Research Symposium - 2007

The UIC/Conquer Chiari Research Symposium was held on June 2nd at the University of Illinois-Chicago.  The event brought together top neurosurgeons and researchers from around the world to present their work and exchange ideas.  Each presentation was recorded and is available via archived webcast (please note requirements below):

Research Symposium 2007 Webcast

Note:  There are two pages of presentations (19 total)

Requirements for viewing webcast:

> Microsoft® Windows 2000, Windows XP,
Windows 2003
> Display resolution of 1024 x 768 pixels or greater
> Windows-compatible sound card
> Microsoft Internet Explorer 6.0 SP1 or greater
> Microsoft Windows Media® Player 9.0 or greater
> Broadband Internet connection (256 Kbps
and above)

If you don't have a broadband connection, most (if not all) public libraries have broadband internet access.  Also note that some network systems will restrict access to streaming video.


Research Agenda

Conquer Chiari has developed, and is actively promoting, the following Research Agenda:

Conquer Chiari Research Agenda:  A Roadmap For Success

Goal #1:  Reduce the average time to an accurate diagnosis to less than 2 years from time of first symptoms.

Objectives:

·      Develop a standard, simple, objective definition and test of symptomatic Chiari

·      Enable the introduction of new technologies, such as inexpensive, portable imaging, which will reduce the barriers to diagnosis

Goal #2:  Develop an effective, widely adopted, and minimally traumatic standard of care.

Objectives:

·      Design, and encourage the adoption of, a standard outcome measure, such that the results from different studies can be compared and combined

·      Establish whether the surgical variations that currently exist have a significant effect on long-term patient outcomes, and further develop a standardized surgical approach

·      Encourage the development of minimally invasive surgical techniques

·      Pursue non-surgical treatment approaches which don't just address symptoms, but are targeted at the core problem(s)

Goal #3:  Minimize the impact that Chiari has on the quality of life of patients.

Objectives:

·      Develop, and encourage the adoption of, a Chiari Impact Measure, which takes into account patient focused issues such as career, family, economics, recreation, and socialization

·      Understand, and develop treatments for, the neuropsychological effects of Chiari, including both cognitive and emotional manifestations

·      Develop widely accepted protocols for physical, occupational, and other types of therapies designed to maximize functional capabilities

·      Enable the development of innovative technologies and treatments targeted at the neuropathic pain and loss of function associated with Chiari

Goal #4:  Understand the pathophysiology, natural history, and epidemiological characteristics of Chiari.

Objectives:

·      Establish, with reasonable accuracy, the incidence and prevalence of Chiari and Chiari related syringomyelia

·      Characterize, and quantify, the Chiari experience, such as average age of diagnosis, time to diagnosis, number of doctors seen, major symptoms, etc.

·      Develop a sound theoretical model for the pathophsyiology of Chiari, which explains how symptoms develop, and will enable predictions about who needs surgery, who will develop syringomyelia, etc.

·      Identify and characterize the genetic basis of Chiari


The Importance Of Research

While much can be accomplished through education and awareness, medical and scientific advances are what will be needed to truly improve the outcomes of patients and to Conquer Chiari once and for all.  Today, Chiari and syringomyelia are poorly understood - from causes to symptoms to treatments  - and patients pay the price for this lack of knowledge.  Imagine a world where Chiari is no big deal....A Vision For The Future

To make this vision a reality the Chiari community needs to become more active in funding research.  Each research project costs a minimum of $50,000 per year,

If you are interested in helping to fund exciting research which can change people's lives, you may specify that your donation be used for Research.  If you do this, 100% of your donation will be applied to Research.

Home | About Us | Links | Donate | Volunteer
Education | Awareness | Research | Privacy Policy

Disclaimer:  This publication is intended for informational purposes only and may or may not apply to you.  The editor and publisher are not doctors and are not engaged in providing medical advice.   Always consult a qualified professional for medical care.  This publication does not endorse any doctors, procedures, or products.

© 2003-2010 C&S Patient Education Foundation